Skip to main content
. 2022 Mar 23;66(2):222–228. doi: 10.20945/2359-3997000000456

Table 2. Glycemic control and daily insulin dose during follow-up in remitter and non remitter patients.

Remitters Non remitters p
HbA1c at 3 months (%) 6.5 ± 1.9 8.5 ± 2.5 0.02
Insulin dose at 3 months (IU/kg/day) 0.42 ± 0.2 0.82 ± 0.3 <0.001
HbA1c at 6 months (%) 5.8 ± 0.6 7.6 ± 2.6 <0.001
Insulin dose at 6 months (IU/kg/day) 0.35 ± 0.2 0.79 ± 0.3 <0.001
HbA1c at 1 year (%) 7.1 ± 1.6 8.7 ± 2.4 0.004
Insulin dose at 1 year (IU/kg/day) 0.37 ± 0.2 0.75 ± 0.3 <0.001
HbA1c at 2 years (%) 7.8 ± 1.8 9.7 ± 2.5 0.004
Insulin dose at 2 years (IU/kg/day) 0.48 ± 0.2 0.73 ± 0.3 0.003
HbA1c at 3 years (%) 8.2 ± 1.9 9.8 ± 2.4 0.032
Insulin dose at 3 years (IU/kg/day) 0.46 ± 0.1 0.78 ± 0.3 0.001
HbA1c at 4 years (%) 7.8 ± 1.8 10.1 ± 2.6 0.008
Insulin dose at 4 years (IU/kg/day) 0.55 ± 0.2 0.82 ± 0.2 0.001
HbA1c at 5 years (%) 8.3 ± 1.2 9.6 ± 2.5 0.018
Insulin dose at 5 years (IU/kg/day) 0.62 ± 0.2 0.78 ± 0.2 0.129